Enbridge (NY:ENB)

45.97 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Enbridge

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

39 40 Next >

This Phenomenal Dividend Stock Can't Stop Adding Fuel to Its Growth Engine ↗

November 08, 2023

Enbridge has been very active in securing new investment opportunities this year.

Via The Motley Fool

Analyst Expectations for Enbridge's Future ↗

November 06, 2023

Via Benzinga

3 Top High-Yielding Dividend Stocks I Can't Wait to Add to in November ↗

November 05, 2023

Three of this Fool's favorite income-producing investments are on sale this month.

Via The Motley Fool

Deluxe Bonds And Dividend Traps ↗

November 04, 2023

Deluxe bonds and dividend traps are often high-yield stocks. Deluxe bonds can play a useful role in your portfolio, but dividend traps can seriously hurt your retirement. It's important to know the...

Via Talk Markets

Topics Bonds Retirement

This 7.6%-Yielding Dividend Stock Showcases Why It's a No-Brainer for Income ↗

November 04, 2023

Enbridge's dividend remains on rock-solid ground.

Via The Motley Fool

Enbridge (ENB) Q3 2023 Earnings Call Transcript ↗

November 03, 2023

ENB earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Earnings Preview: Enbridge ↗

November 02, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Enbridge ↗

October 12, 2023

Via Benzinga

Dominion Energy Q3 Revenue Misses Consensus, Profits Decline Across Segments ↗

November 03, 2023

Dominion Energy Inc (NYSE: D) reported Q3 FY23

Via Benzinga

Enbridge Q3: Earnings Decline On Ongoing Market Volatility, Reaffirms FY23 Outlook ↗

November 03, 2023

Enbridge Inc (NYSE: ENB) reported Q3 FY23 adjusted

Via Benzinga

Earnings Scheduled For November 3, 2023 ↗

November 03, 2023

Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.

Via Benzinga

Energy Stocks for Long-Term Growth: 3 Companies to Watch ↗

October 31, 2023

These energy stocks can deliver compounded growth for long-term investors. Make sure you add these stocks to your watchlist.

Via InvestorPlace

The 3 Highest-Paying Dividend Stocks for Income Loving Investors ↗

October 29, 2023

Looking for safe high yields? These are the three top highest-paying dividend stocks that you should own today.

Via InvestorPlace

3 No-Brainer Dividend Stocks for a Volatile Oil Market ↗

October 29, 2023

These energy companies are relatively immune to the ebbs and flow of oil and gas prices.

Via The Motley Fool

3 Great Foreign Companies to Invest in Right Now ↗

October 26, 2023

If you are looking for opportunities abroad, you'll want to examine Unilever, Enbridge, and TotalEnergies today.

Via The Motley Fool

7 Energy Stocks That Have Much More Room to Run ↗

October 22, 2023

With society facing the mathematical reality of population growth, investors should consider these energy stocks with upside potential.

Via InvestorPlace

Hedging With Energy ↗

October 22, 2023

It’s always interesting to learn how financial advisers use our energy infrastructure investments in their portfolios. Often, it’s for income, because the 6-7% yields are well covered by cash flow.

Via Talk Markets

The Biden Administration Is Spending $7 Billion on This Renewable Fuel, and These Stocks Stand to Benefit ↗

October 20, 2023

The administration announced the recipients for $7 billion for seven large hydrogen hubs around the U.S.

Via The Motley Fool

3 Ultra High-Yield Dividend Stocks Down 22% to 73% to Buy on the Dip ↗

October 20, 2023

Falling share prices have pushed these dividend yields even higher.

Via The Motley Fool

A Bull Market Is Coming: These Top Stocks Can Help You Earn More Dividend Income ↗

October 19, 2023

High-yield dividend stocks can put more cash in your pocket.

Via The Motley Fool

7 Energy Stocks to Invest in to Power Up Your Profits ↗

October 18, 2023

Explore seven of the top energy stocks to invest in right now to effectively capitalizing on commodity surges.

Via InvestorPlace

7 Steady Stocks to Fortify Your Portfolio Against Uncertainty ↗

October 17, 2023

With potential storms coming over the horizon, investors may want to consider these steady stocks for uncertain times.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023 ↗

October 17, 2023

Via Benzinga

3 Energy Stocks to Buy Hand Over Fist in October ↗

October 17, 2023

These companies can provide investors with consistent income for some time to come.

Via The Motley Fool

The 7 Best Oil Stocks To Buy Now: October 2023 ↗

October 16, 2023

With geopolitical flashpoints contributing to an artificial supply constraint, circumstances look cynically robust for the best oil stocks.

Via InvestorPlace

Cut Your Losses: Sell These 7 Weak Stocks Now ↗

October 16, 2023

You can't let weakness in a company or the market damage your portfolio. Avoid disappointing returns by moving on these stocks to sell.

Via InvestorPlace

3 Stocks I Want to Own for the Rest of My Life ↗

October 16, 2023

Building wealth may be as simple as holding shares of great companies you already own.

Via The Motley Fool

Up 19%, Is This 9%-Yielding Dividend Stock Still a Good Buy? ↗

October 13, 2023

Energy Transfer has been on a roll over the past year.

Via The Motley Fool

3 Bargain-Basement Growth Stocks to Buy on the Dip ↗

October 12, 2023

These stocks look like bargain buys right now.

Via The Motley Fool

2 No-Brainer Dividend Stocks to Buy With $200 Right Now ↗

October 12, 2023

If you have a couple of hundred dollars, here are two very attractive income stocks to buy in the energy patch.

Via The Motley Fool

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.